HUMAN DISEASE MODELED by slc24a5^b1/+ + MO2-musk

Human Disease	Conditions	Citations
congenital myasthenic syndrome	standard conditions	McMacken et al., 2018

GENE EXPRESSION
Gene expression in slc24a5^b1/+ + MO2-musk

PHENOTYPE
Phenotype in slc24a5^b1/+ + MO2-musk

Phenotype	Conditions	Figures
motor neuron axon branchiness, abnormal	chemical treatment by environment: ICI 118551, chemical treatment by environment: albuterol	Fig. 4  from McMacken et al., 2018
motor neuron axon branchiness, abnormal	standard conditions	Fig. 3  from McMacken et al., 2018
motor neuron axon morphology, ameliorated	chemical treatment by environment: albuterol	Fig. 3  from McMacken et al., 2018
motor neuron axon morphology, ameliorated	chemical treatment by environment: forskolin	Fig. 5  from McMacken et al., 2018
motor neuron axon truncated, abnormal	standard conditions	Fig. 3  from McMacken et al., 2018
motor neuron axon truncated, abnormal	chemical treatment by environment: ICI 118551, chemical treatment by environment: albuterol	Fig. 4  from McMacken et al., 2018
myotome cholinergic synapse amount, ameliorated	chemical treatment by environment: albuterol	Fig. 3  from McMacken et al., 2018
myotome cholinergic synapse decreased amount, abnormal	standard conditions	Fig. 3  from McMacken et al., 2018